Recommended Infection-Control Policies for Patients with Human Immunodeficiency Virus Infection
- 11 December 1986
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 315 (24) , 1562-1564
- https://doi.org/10.1056/nejm198612113152434
Abstract
Efforts to contain the epidemic of the acquired immunodeficiency syndrome (AIDS) have concentrated on preventing the transmission of human immunodeficiency virus (HIV, or HTLV-III/LAV), since neither curative therapies nor vaccination is likely to become available in the near future. Infection control is a particularly important issue in the health care facility, where frequent and intensive exposure to infected patients may occur.Because of the identification of HIV as the causative agent in AIDS and the consequent development of culture techniques and serologic methods for detecting antibody to the virus, it is now possible to identify both symptomatic and asymptomatic infected . . .Keywords
This publication has 7 references indexed in Scilit:
- Risk of Nosocomial Infection with Human T-Cell Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus in a Large Cohort of Intensively Exposed Health Care WorkersAnnals of Internal Medicine, 1986
- Occupational Risk of the Acquired Immunodeficiency Syndrome among Health Care WorkersNew England Journal of Medicine, 1986
- HTLV-III Infection Among Health Care WorkersJAMA, 1985
- Prevalence of HTLV-III Antibody in American Blood DonorsNew England Journal of Medicine, 1985
- POSTNATAL TRANSMISSION OF AIDS-ASSOCIATED RETROVIRUS FROM MOTHER TO INFANTThe Lancet, 1985
- Risk of Nosocomial Infection with Human T-Cell Lymphotropic Virus III (HTLV-III)New England Journal of Medicine, 1985
- Infection-Control Guidelines for Patients with the Acquired Immunodeficiency Syndrome (AIDS)New England Journal of Medicine, 1983